Distinct Healthcare, Q&M Dental Group, and others release financial reports; Angel Aligner ruled by Jinan Intermediate Court in first instance to infringe Align Technology’s patent, states business o…

Jinan Intermediate Court ruled in first instance that Angelalign's A7 extraction plan infringed Align Technology's patent. Angelalign: business operations normal, will appeal.

On August 11, 2026, the Jinan Intermediate People's Court issued a first-instance judgment in the patent infringement lawsuit filed by Invisalign parent company Align Technology against Angelalign's operating entities in China (including Shanghai Angelalign Medical Device Co., Ltd., Wuxi Angelalign Medical Device Technology Co., Ltd., and Wuxi Angelalign Biotechnology Co., Ltd.), finding that Angelalign's use of specific patented technology to generate orthodontic treatment plans involving premolar extraction constituted infringement. The court ordered compensation of RMB 10 million and ordered the cessation of use of the patented technology in question, as well as the cessation of production and sale of the products found to infringe. Angelalign stated on August 13 that the judgment has not yet taken effect and has no immediate impact on clients and patients, and that it will appeal the ruling.

Distinct Healthcare 2026H1: Revenue RMB 596 million, up 17% YoY; Dental revenue up 48.6%

On August 13, 2026, Distinct Healthcare announced its first-half results: revenue of RMB 596 million, up 17% YoY; net profit of RMB 83.39 million, up 10.5% YoY; adjusted net profit of RMB 28.402 million, turning profitable from a loss; dental revenue of RMB 116 million, up 48.6% YoY. As of June 30, 2026, the company operated 18 locations, with 35% of AI funds planned for investment in artificial intelligence; net cash from operating activities was RMB 65.16 million, with cash and cash equivalents of approximately RMB 292 million at period end.

Q&M Dental Group 2026H1: Revenue RMB 524 million, dental business up 13.01% YoY

On July 10, 2026, Singapore-listed dental chain Q&M Dental Group announced its first-half 2026 results, with cumulative revenue of approximately RMB 524 million and net profit attributable to shareholders of the parent company up 27% YoY. The company's dental business generated revenue of approximately RMB 519 million in 1H26, up 13.01% YoY, accounting for 99.08% of total revenue; growth was primarily driven by increased contributions from dental clinics in Singapore and Malaysia, as well as revenue growth in China from the consolidation of Aoxin Q&M Dental Group. Additionally, the company announced plans to invest approximately RMB 760 million to acquire 39 clinics under Experteeth in Australia and 33 clinics under Deezy Q&M in Thailand, accelerating its global expansion.

US-listed dental DSO company 2026Q2: Revenue USD 66.21 million, up 5.1%; Net profit down 47.5% YoY

On August 12, 2026, Park Dental Partners (Nasdaq: PARK) reported its second-quarter 2026 financial results, with quarterly revenue of USD 66.212 million, up 5.1% YoY; GAAP net profit was only USD 1.349 million, down 47.5%. The company plans to acquire Village Family DSO in North Carolina for approximately USD 39.1 million to 46 million, expanding its footprint to a fourth US state.

India B2B2C dental products company Laxmi Dental Q1FY27: Revenue approximately RMB 53.04 million, up 13.9% YoY

On August 11, 2026, Indian B2B2C dental company Laxmi Dental Limited reported its first-quarter results for fiscal year 2027. The company posted quarterly revenue of INR 747 million (approximately RMB 53.04 million), up 13.9% YoY; net profit attributable to shareholders of the parent company was INR 103 million (approximately RMB 7.31 million), up 23.8% YoY. Gross margin improved to 78.6%, international business revenue reached INR 242 million, up 37.4% YoY, and clear aligner revenue was INR 238 million, up 28.6% YoY. The company stated it will focus on its core dental product portfolio, strengthen market penetration, and improve operational efficiency through AI automation.

Aoxin Q&M Dental Group plans to invest RMB 35 million in a new dental hospital in Shenyang, with a construction area of approximately 2,430 square meters

On August 12, 2026, Aoxin Q&M Dental Group signed a cooperation memorandum with the Shenhe District Government in Shenyang, planning to invest approximately RMB 35 million to build a new dental hospital of 2,430 square meters at No. 88-7 Wenhua Road, with trial operations expected by the end of September 2026. The hospital will be staffed by over 80 professional medical personnel and 20 auxiliary staff, offering comprehensive dental services including endodontics, periodontics, prosthodontics, implant dentistry, and orthodontics. Property handover has been completed, and interior construction is proceeding as planned.

RMB 1.228 billion share transfer completed, LMZ's ultimate controller changed

On August 3, 2026, three shareholders in Liuzhou transferred 154,000,000 shares of LMZ (representing 28% of total share capital, at RMB 7.9742 per share, with a total transfer price of approximately RMB 1.228 billion) to Guangxi State-owned Capital Control Operation Group through registration of ownership transfer. The company's ultimate controller changed from Liuzhou SASAC to Guangxi Zhuang Autonomous Region SASAC, with Guangxi State-owned Capital holding 28% and a combined approximately 29.59% with Guangxi Industrial Investment. Guangxi State-owned Capital has issued commitments to maintain the independence of the listed company, avoid horizontal competition, and regulate related-party transactions.

*ST HILE's controlling shareholder changed to ultimate controller Zhang Haiming: Father and daughter acquire all 34.70% shares for RMB 600 million

On August 14, 2026, *ST HILE disclosed that its controlling shareholder, Shanghai Haoyuan, transferred its 34.70% stake to ultimate controller Zhang Haiming and his daughter Zhang Yue at RMB 2.655 per share, with a total price of approximately RMB 601 million. Zhang Haiming acquired 24.29% of the shares, and Zhang Yue acquired 10.41%. After the transfer, Zhang Haiming remains the direct controlling shareholder, with combined shareholding maintained at 37.91%. The company had previously established a secondary management platform through Ruisheng Biology to centrally manage seven Jinboli Dental Clinic locations in Yangzhou and Changzhou.

Digital dentistry platform and healthcare services platform reach strategic partnership, bringing sleep and metabolic health into dental care

On August 12, 2026, US digital dentistry platform Dentulu signed a strategic partnership with healthcare services platform Guide GLP, embedding physician-supported metabolic health and sleep screening into Dentulu's national digital platform. Patients can track systemic indicators such as blood glucose and blood pressure, while dentists focus on dental procedures and physicians handle diagnosis and prescriptions. Guide GLP CEO Gibb Clark stated this provides an opportunity to bring physician-supervised healthcare services into new care settings.

Dental education company embeds front-office training into AI communications platform, connecting call data with just-in-time training

On August 10, 2026, Spear Education partnered with dental AI communications platform VoiceStack to embed front-office training resources directly into the platform, offering practical courses on case acceptance, scheduling management, and fee presentation. Spear's Director of Strategic Partnerships Aimee Fletcher emphasized that front-office performance affects patient experience, and non-VoiceStack users can access the same training through Spear Practice Membership. VoiceStack Vice President Neil Hoover stated the platform can identify call loss points and instantly retrieve corresponding training content.

Ireland proposes legislation mandating continuing professional development training for dentists

On August 7, 2026, the Irish government formally approved the draft outline of the Dentists (Amendment) Bill, which for the first time statutorily requires dentists to undertake Continuing Professional Development (CPD) and grants the Dental Council broader regulatory powers to proactively take regulatory action against registered dentists who fail to meet training requirements, without waiting for competency complaints. The amendment will give dental CPD a statutory foundation, marking the first time in the 40 years since the Dentists Act 1985 that dental CPD regulatory standards will be aligned with other regulated healthcare professions.

First mandatory dental premium rebate mechanism in the US takes effect, 83% loss ratio threshold may serve as legislative reference for other states

On August 6, 2026, the Massachusetts Division of Insurance announced that nine health and dental insurers, having failed to meet the 83% Dental Loss Ratio (DLR) threshold, will return a total of USD 14.5 million in premiums to hundreds of thousands of consumers in the state. Six dental insurance companies will return USD 8.4 million, and three health insurance companies will return USD 6.1 million. Refunds will be issued via check or future premium credits, with distribution expected to begin later this month.

Unapproved Class III dental devices circulated nationwide for seven years; DOJ sues manufacturer seeking permanent injunction

On August 6, 2026, the US Department of Justice filed a civil complaint in Nevada federal court seeking a permanent injunction against Steiner Biotechnology LLC and its co-owners, alleging long-term nationwide distribution of unapproved Class III dental devices. The complaint lists multiple synthetic bone graft materials and dental cements, including Socket Graft Plus and Immediate Graft. The FDA conducted multiple inspections of the company between 2018 and 2025 and found repeated violations. Steiner had not publicly responded to the lawsuit as of press time.

Dental school introduces AI virtual patients to enhance pre-clinical communication skills and medical history taking

On August 10, 2026, the University of Colorado Anschutz School of Dental Medicine deployed AI virtual patients including John and Judy to help students improve communication skills and medical history taking before clinical rotations. The first batch of virtual humans simulates basic patient intake, while advanced versions such as Jessica and Greg incorporate complex scenarios including mental health screening, with adjustable difficulty, language options, and repeat practice support. The school plans to extend the technology to augmented reality spaces, allowing virtual humans to enter real treatment rooms or waiting areas.

Dental implant robotics market could exceed USD 1.7 billion by 2036, with CAGR of 25%

In August 2026, Future Market Insights released the "Dental Implant Robotics Market Report," projecting the global dental implant robotics market will grow from USD 188 million in 2026 to USD 1.751 billion by 2036, representing a CAGR of approximately 25%. The report states that haptic-guided robotic arms accounted for 56% of the market in 2026, with single-tooth implantation contributing 44%; the US is growing at 26% annually, the EU at 23%, and China is actively positioning itself. In April 2026, Guangdong Province set a price ceiling of RMB 1,033 per unit for 3D guides for dental implantation, with robotic-assisted surgery fees chargeable at up to 300% of the primary surgical fee. The report also noted that equipment procurement and training costs remain major constraints, with the American Dental Association showing that equipment and consumables prices rose more than 5% YoY in the first five months of 2025.

New study: Omega-3 combined with low-dose aspirin for severe periodontitis may be comparable to antibiotics

A recent multicenter, double-blind, randomized clinical trial showed that Omega-3 (3 g/day) combined with low-dose aspirin (100 mg/day) as an adjunct to subgingival scaling and root planing achieved a treatment success rate of 57.7% at one-year follow-up, comparable to the 58.6% achieved with traditional antibiotic regimens, and both significantly higher than the 23.1% observed with scaling alone. The study enrolled 109 adult patients with severe periodontitis across multiple hospitals in Brazil and the United States. The research team has initiated microbiological analysis to explore the therapy's effects on the bacterial composition of periodontal pockets.